← Holders
Rhenman & Partners Asset Management AB
What Rhenman & Partners Asset Management AB reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1599882 · Filed Nov 12, 2026
- Positions
- 93
- Reported value
- $902.9M
- Opened
- 16
- Closed
- 22
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$903.7M92 positions
- Dec 31, 2025$1.1B94 positions
- Mar 31, 2026$810.5M86 positions
- Jun 30, 2026$1.1B99 positions
- Sep 30, 2026$902.9M93 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
IOVAIovance Biotherapeutics, Inc. | 2.5M | +46.8% | $37.1M | 4.1% |
AZNAstraZeneca PLC | 185K | +22.1% | $30.3M | 3.4% |
MRKMerck & Co., Inc. | 206.9K | −3.1% | $30.1M | 3.3% |
MDTMedtronic plc | 340K | +134.5% | $29.3M | 3.2% |
UNHUnitedHealth Group Inc | 71.4K | −23.7% | $26.2M | 2.9% |
VRTXVertex Pharmaceuticals Inc | 48.9K | +59.5% | $25.6M | 2.8% |
GILDGilead Sciences, Inc. | 159.1K | −10.8% | $23.7M | 2.6% |
EWEdwards Lifesciences Corp | 273K | +5.0% | $23.6M | 2.6% |
BMRNBioMarin Pharmaceutical Inc | 386.9K | +33.2% | $23.2M | 2.6% |
BIIBBiogen Inc. | 97.1K | +2.3% | $21.9M | 2.4% |
LLYEli Lilly & Co | 18.9K | −15.4% | $21.8M | 2.4% |
INSMInsmed Inc | 187.1K | +23.1% | $21.4M | 2.4% |
CVSCVS Health Corp | 220.4K | −21.1% | $18.9M | 2.1% |
CORCencora, Inc. | 62.5K | +33.6% | $18.8M | 2.1% |
AXSMAxsome Therapeutics, Inc. | 97.7K | +55.0% | $18M | 2% |
ABBVAbbVie Inc. | 61.6K | −36.3% | $16.1M | 1.8% |
JAZZJazz Pharmaceuticals plc | 67.8K | −22.4% | $15.7M | 1.7% |
JNJJohnson & Johnson | 58.5K | −19.3% | $15.5M | 1.7% |
MCKMcKesson Corp | 17.9K | +7.9% | $15.2M | 1.7% |
DHRDanaher Corp | 68.5K | −14.7% | $15.2M | 1.7% |
CNCCentene Corp | 237.5K | −2.7% | $14.8M | 1.6% |
REGNRegeneron Pharmaceuticals, Inc. | 19.3K | −29.4% | $14.7M | 1.6% |
CRLCharles River Laboratories International, Inc. | 46.8K | −18.2% | $13.8M | 1.5% |
BSXBoston Scientific Corp | 315K | −30.1% | $13.7M | 1.5% |
ISRGIntuitive Surgical Inc | 33.5K | −2.9% | $13.6M | 1.5% |
GHGuardant Health, Inc. | 76.3K | −33.7% | $13.6M | 1.5% |
THCTenet Healthcare Corp | 52.8K | −38.0% | $13.5M | 1.5% |
AAgilent Technologies, Inc. | 78K | +4.0% | $13.4M | 1.5% |
ALKSAlkermes plc. | 302.6K | +63.4% | $12.3M | 1.4% |
AVRAnteris Technologies Global Corp. | 1.5M | ±0% | $12M | 1.3% |
NBIXNeurocrine Biosciences Inc | 81.3K | −5.3% | $11.5M | 1.3% |
ALHCAlignment Healthcare, Inc. | 1.4M | +38.4% | $11.3M | 1.2% |
BTSGBrightSpring Health Services, Inc. | 192.9K | +16.3% | $10.9M | 1.2% |
LIVNLivaNova PLC | 140K | −14.6% | $10.7M | 1.2% |
TMOThermo Fisher Scientific Inc. | 15.6K | −50.7% | $10.5M | 1.2% |
NRIXNurix Therapeutics, Inc. | 439.5K | −35.8% | $10.4M | 1.2% |
UTHRUnited Therapeutics Corp | 19.2K | New | $10.4M | 1.1% |
COOCooper Companies, Inc. | 181.5K | +236.1% | $10.3M | 1.1% |
PRCTPROCEPT BioRobotics Corp | 535K | +55.1% | $9.7M | 1.1% |
PNTGPennant Group, Inc. | 236.5K | −36.3% | $9.2M | 1% |
ERASErasca, Inc. | 608.8K | +74.4% | $8.9M | 1% |
RPRXRoyalty Pharma plc | 141K | −28.4% | $8.2M | 0.9% |
EHCEncompass Health Corp | 66.3K | −10.8% | $8.1M | 0.9% |
MIRMMirum Pharmaceuticals, Inc. | 91.9K | −34.0% | $7.9M | 0.9% |
VERAVera Therapeutics, Inc. | 242.5K | New | $7.8M | 0.9% |
ARWRArrowhead Pharmaceuticals, Inc. | 112.5K | −12.1% | $7.4M | 0.8% |
SYRESpyre Therapeutics, Inc. | 78.6K | −34.1% | $7M | 0.8% |
OSCROscar Health, Inc. | 220K | −43.9% | $6.8M | 0.8% |
CYTKCytokinetics Inc | 102.8K | New | $6.8M | 0.8% |
STVNStevanato Group S.p.A. | 316.8K | New | $6.6M | 0.7% |
DNTHDianthus Therapeutics, Inc. | 75K | −12.9% | $6.6M | 0.7% |
HUMHumana Inc | 17K | New | $6.5M | 0.7% |
SNDXSyndax Pharmaceuticals Inc | 342.3K | −38.9% | $6.4M | 0.7% |
ALNYAlnylam Pharmaceuticals, Inc. | 25.9K | +50.6% | $6.4M | 0.7% |
DXCMDexCom Inc | 73K | −54.4% | $6.3M | 0.7% |
RLAYRelay Therapeutics, Inc. | 343.5K | −39.3% | $6.2M | 0.7% |
NKTRNektar Therapeutics | 98.4K | −30.4% | $6M | 0.7% |
GPCRStructure Therapeutics Inc. | 183.3K | +26.3% | $5.7M | 0.6% |
IDYAIDEAYA Biosciences, Inc. | 140.2K | −59.2% | $5.4M | 0.6% |
KURAKura Oncology, Inc. | 501.1K | −15.3% | $5.4M | 0.6% |
TGTXTG Therapeutics, Inc. | 90.5K | +1,710.0% | $5M | 0.6% |
ABTAbbott Laboratories | 49.5K | −48.4% | $4.9M | 0.5% |
ORKAOruka Therapeutics, Inc. | 55.9K | −30.1% | $4.7M | 0.5% |
WAYWaystar Holding Corp. | 169.2K | −5.3% | $4.3M | 0.5% |
AGLagilon health, inc. | 52.9K | +958.5% | $4.2M | 0.5% |
PODDInsulet Corp | 32K | −23.8% | $4.2M | 0.5% |
OCULOcular Therapeutix, Inc | 512K | +127.6% | $3.9M | 0.4% |
BBIOBridgeBio Pharma, Inc. | 57.1K | −37.3% | $3.8M | 0.4% |
SMMTSummit Therapeutics Inc. | 215K | New | $3.6M | 0.4% |
MBXMBX Biosciences, Inc. | 62K | ±0% | $3.6M | 0.4% |
VCELVericel Corp | 90K | +28.6% | $3.6M | 0.4% |
GKOSGlaukos Corp | 22K | −81.5% | $3.6M | 0.4% |
ROIVRoivant Sciences Ltd. | 82.5K | New | $3M | 0.3% |
MDGLMadrigal Pharmaceuticals, Inc. | 5.7K | −29.8% | $2.8M | 0.3% |
ASTHAstrana Health, Inc. | 79.6K | −33.1% | $2.8M | 0.3% |
KRYSKrystal Biotech, Inc. | 8.2K | −49.6% | $2.7M | 0.3% |
INNVInnovAge Holding Corp. | 279K | New | $2.5M | 0.3% |
DNLIDenali Therapeutics Inc. | 113.6K | −36.5% | $2.3M | 0.3% |
ADPTAdaptive Biotechnologies Corp | 72.5K | New | $2.1M | 0.2% |
RYTMRhythm Pharmaceuticals, Inc. | 19K | New | $1.8M | 0.2% |
STOKStoke Therapeutics, Inc. | 61K | −5.4% | $1.6M | 0.2% |
TNGXTango Therapeutics, Inc. | 60K | New | $1.5M | 0.2% |
PRVAPrivia Health Group, Inc. | 66K | +32.0% | $1.3M | 0.1% |
XENEXenon Pharmaceuticals Inc. | 33.7K | +1.4% | $1.3M | 0.1% |
ENSGEnsign Group, Inc | 3.8K | New | $645K | 0.1% |
TXG10x Genomics, Inc. | 5.3K | −37.6% | $478.9K | 0.1% |
SIONSionna Therapeutics, Inc. | 87.5K | −9.9% | $460.3K | 0.1% |
CAICaris Life Sciences, Inc. | 15K | New | $459.5K | 0.1% |
BBNXBeta Bionics, Inc. | 20K | New | $379.6K | 0.1% |
BRKRBruker Corp | 4.5K | New | $291.4K | 0.1% |
SYKStryker Corp | 1K | −98.5% | $275.4K | 0.1% |
AMNAMN Healthcare Services Inc | 7.2K | −95.0% | $258.3K | 0.1% |
SCIService Corp International | 3.2K | New | $243.7K | 0.1% |